🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lund
Clinical trial register · Sweden

Clinical Trials in Lund, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2213 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
2213
Studies in scope
all four open statuses
1238
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 924 Gothenburg 632 Lund 402 Uppsala 366 Linköping 237
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Region Skane64 Lund University22 AstraZeneca21 Karolinska Institutet13 Lund University Hospital12
Site location
Stockholm924 Gothenburg632 Lund402 Uppsala366 Linköping237
All 146 locations
Target enrolment
to

Trials with a site in Lund

402 of 2213 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
Standalone Thoracoscopic Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation
NCT07705282ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Oral Anticoagulation, Thoracotomy
Region Skane
Not applicable
936
Lund
2028-01-01
Not yet open
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
NCT07789483Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
DrugALXN2220
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Skellefte, Lund, Gothenburg, Stockholm
2027-11-23
Not yet open
Reduced-Dose Versus Full-Dose Alteplase for High-Risk Pulmonary Embolism
NCT07816978Pulmonary Embolism Acute
DrugAlteplase
Sahlgrenska University Hospital
Phase 4
400
Gothenburg, Falun, Jönköping, Lund, Malmö, Mölndal, Norrtälje, Skövde
2026-12-01
Not yet open
REcovery After Cancer Application
NCT07642492Oesophageal Cancer, Gastric Cancer (Diagnosis)
Karolinska Institutet
Not applicable
250
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2026-09-15
Not yet open
Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression
NCT07664852Bipolar Disorder (BD)
DrugPramipexole
Daniel Lindqvist
Phase 3
126
Lund
2026-09-01
Recruiting
Internet-Delivered Acceptance and Commitment Therapy (iACT) for Youth With PTSD and Chronic Pain
NCT07813728Chronic Pain, PTSD
Skane University Hospital
Not applicable
10
Lund
2026-09-01
Not yet open
Effects of Microelectrode-based Brain Stimulation in Humans
NCT07820189Essential Tremor, Parkinsons Disease (PD)
Lund University
Not applicable
12
Lund
2026-09
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Gothenburg, Jönköping, Karlstad, Lund, Mölndal, Örebro, Stockholm, Uppsala
2026-08-24
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
NCT07776509Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2
DrugAZD6234
AstraZeneca
Phase 3
500
Linköping, Lund, Mölndal, Örebro, Stockholm
2026-08-24
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993Chronic Kidney Disease
DrugElecoglipron
AstraZeneca
Phase 3
7,000
Falun, Gothenburg, Karlstad, Linköping, Lund, Örebro, Stockholm, Uppsala
2026-08-21
Recruiting
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
NCT07745504Overweight, Obesity
DrugCagrilintide
Novo Nordisk A/S
Phase 3
285
Lund, Mölndal, Örebro, Rättvik
2026-08-04
Recruiting
Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice
NCT07651891Allergic Rhinitis, Asthma (Diagnosis)
Karolinska Institutet
Phase 4
40
Lund, Trelleborg
2026-08-01
Recruiting
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
NCT07169747Anorexia Nervosa
DrugPsilocybin
Region Skane
Phase 2
40
Lund
2026-07-20
Active, closed
Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test
NCT07340567Colorectal Cancer
DrugsFolfirinox·Folfox·Capecitabine·Oxaliplatin
UNICANCER
Phase 3
2,450
Gothenburg, Lund, Stockholm, Uppsala
2026-07-20
Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
NCT07544654Extrapulmonary Neuroendocrine Cancer (epNEC)
DrugsObrixtamig·Etoposide·Carboplatin
Boehringer Ingelheim
Phase 3
390
Gothenburg, Lund, Uppsala
2026-07-10
Recruiting
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
NCT07764978Newly Diagnosed Multiple Myeloma
DrugsAZD0120·Isatuximab·Bortezomib·Daratumumab
AstraZeneca
Phase 3
750
Gothenburg, Huddinge, Lund
2026-06-26
Active, closed
A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM
NCT07608354Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
DrugsALXN2220·Eplontersen
AstraZeneca
Phase 2
326
Gothenburg, Lund, Stockholm, Uppsala
2026-06-11
Recruiting
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
NCT07192952Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
DrugFinerenone
Bayer
Phase 3
117
Lund
2026-06-01
Recruiting
To Evaluate If Preoperative 7 Days Low Calorie Diet Reduces Postoperative Morbidity in Liver Surgery
NCT07801716Surgical Complications
Region Skane
Not applicable
200
Lund
2026-06-01
Recruiting
A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients
NCT07839793PARKINSON DISEASE (Disorder)
Navamedic AB
Phase 4
58
Stockholm, Uppsala, Gothenburg, Lund
2026-05-25
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT07517263Cardiovascular Disease and Lipoprotein(a)
DrugPelacarsen
Novartis Pharmaceuticals
Phase 3
5,700
Gothenburg, Lund, Stockholm
2026-05-11
Recruiting
Efficacy of L-menthol on Breathlessness in Asthma
NCT07500974Asthma
DrugL-menthol
Region Skane
Phase 2
20
Karlskrona, Lund
2026-05-07
Recruiting
The Study Tests if Preoperative Dental Screening is Superior to no Preoperative Dental Screening in Improving the Outcome of Patients Undergoing Surgical Cardiac Valve Replacement or Transcatheter Cardiac Valve Implantation.
NCT07511673Infective Endocarditis (IE), Heart Valve Disease
Region Skane
Not applicable
1,300
Gothenburg, Linköping, Lund, Örebro, Stockholm
2026-05-06
Recruiting
ClusterVAP: Multicentre Proteomic Endotyping of Ventilator-associated Pneumonia
NCT07245888Ventilator Acquired Pneumonia, Mechanical Ventilation Complication
Region Skane
Observational
400
Lund, Stockholm
2026-05-01
Recruiting
Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
NCT07398287Interstitial Lung Disease (ILD)
DrugL-menthol
Region Skane
Phase 2
20
Karlskrona, Lund
2026-04-13
Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
NCT07522073Solid Tumors
DrugINCB161734
Incyte Corporation
Phase 3
588
Linköping, Lund, Stockholm
2026-04-09
Not yet open
Simplified Exercise-based Risk Assessment in Lung Cancer
NCT07506889Lung Cancer (Diagnosis), Lobectomy, Surgery Complications, Neoadjuvant Chemoimmunotherapy
Linkoeping University
Observational
500
Jönköping, Kalmar, Karlskrona, Linköping, Lund
2026-04-01
Recruiting
Non-Invasive Hemodynamic Monitoring in Hospitalized Heart Failure
NCT07671742Heart Failure, Heart Failure Hospitalization, Heart Failure (HF)
Acorai AB
Observational
1,000
Lund
2026-04-01
Recruiting
Internet-Delivered ACT Targeting Emotional Distress and Chronic Pain
NCT07426367Chronic Pain
Skane University Hospital
Not applicable
10
Lund
2026-04-01
Recruiting
Selenium Intervention Registry Randomized Trial in Heart Failure
NCT07543562Heart Failure, Heart Failure and Reduced Ejection Fraction, Heart Failure and Mildly Reduced Ejection Fraction, Heart Failure and Preserved Ejection Fraction
Skane University Hospital
Phase 3
4,326
Malmö, Gothenburg, Jönköping, Linköping, Lund, Örebro, Stockholm, Umeå
2026-04-01
Recruiting
Sleep and Stroke Rehabilitation Study
NCT07579871Stroke, Sleep Apnea Syndrome (OSAS), Insomnia, Excessive Daytime Sleepiness
Malin Eleonora av Kák Gustafsson, MD, PhD
Observational
226
Lund
2026-03-18
Active, closed
A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression
NCT07396272Major Depressive Disorder (MDD)
Daniel Lindqvist
Phase 2
12
Lund
2026-03-13
Recruiting
Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke
NCT06975696Stroke Acute
Region Skane
Not applicable
300
Lund, Örebro
2026-03-02
Recruiting
Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery
NCT07351149Acute Kidney Injury
Uppsala University
Observational
2,000
Gothenburg, Lund, Stockholm, Uppsala
2026-03-01
Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
NCT07223814Acute Myeloid Leukemia
DrugsBleximenib·Idarubicin·Daunorubicin·Cytarabine
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Lund
2026-03-01
Recruiting
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
NCT07220083Focal Segmental Glomerulosclerosis
DrugApecotrep
Boehringer Ingelheim
Phase 3
286
Linköping, Lund, Stockholm, Uppsala
2026-02-16
Recruiting
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
NCT07222332Diabetes Mellitus, Type 1
DrugBaricitinib
Eli Lilly and Company
Phase 3
300
Lund, Örebro, Östersund, Stockholm, Uddevalla
2026-02-05
Not yet open
Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis
NCT07413081Cardiac Amyloidosis, Pacemaker
Region Skane
Not applicable
34
Gothenburg, Linköping, Lund, Skellefteå, Stockholm, Umeå, Uppsala
2026-02-01
Recruiting
Virtual Planning of Total Temporomandibular Joint Replacement
NCT07373184Temporomandibular Disorders (TMD), Temporomandibular Joint Ankylosis
Lund University Hospital
Observational
30
Lund
2026-02-01
Recruiting
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
NCT06594393Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa
Xinnate AB
Phase 2
32
Lund, Uppsala
2026-01-30
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
NCT07216703Cervical Cancer
DrugsSacituzumab tirumotecan·Paclitaxel·Bevacizumab·Cisplatin
Merck Sharp & Dohme LLC
Phase 3
1,023
Lund, Stockholm, Linköping
2026-01-19
Recruiting
Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not
NCT07273409Pancreatic Neuroendocrine Tumor
Uppsala University
Not applicable
200
Gothenburg, Lund, Stockholm, Uppsala
2026-01-09
Recruiting
Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use
NCT07245862Adolescent Behavior, Social Media Addiction, Gaming Disorder, Family Relations
Region Skane
Not applicable
170
Lund
2026-01-01
Active, closed
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
NCT07455097Intermediate-risk Prostate Cancer, High-risk Prostate Cancer
Heinrich-Heine University, Duesseldorf
Observational
600
Lund
2026-01-01
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
NCT07218809Epithelial Ovarian Cancer
DrugsTorvutatug samrotecan·MIRV·Mirvetuximab Soravtansine·Pegylated liposomal doxorubicin
AstraZeneca
Phase 3
1,100
Linköping, Lund, Solna, Umeå, Uppsala
2025-12-29
Recruiting
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
NCT06932562Multiple Myeloma
DrugsLinvoseltamab·Daratumumab·Lenalidomide·Dexamethasone
European Myeloma Network B.V.
Phase 3
1,000
Lund
2025-12-23
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
NCT07285213Clostridioides Difficile Infection
AstraZeneca
Phase 2
230
Helsingborg, Lund, Malmö, Västerås
2025-12-10
Recruiting
Evaluation of Three Tests to Assess Social Cognition in Huntington Disease
NCT07253038Huntington Disease
Region Skane
Observational
40
Lund
2025-12-01
Recruiting
Febrile Infants Swedish Study
NCT07134751Febrile Illness Acute, Meningitis, Bacterial, Urinary Tract Infection (Diagnosis), Invasive Bacterial Infection
Region Skane
Observational
2,000
Gothenburg, Helsingborg, Jönköping, Kristianstad, Lund, Malmö, Örebro, Stockholm
2025-12-01
Recruiting
Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care
NCT07236944Febrile Urinary Tract Infection
DrugPivmecillinam
Uppsala University
Phase 4
560
Borås, Eskilstuna, Gothenburg, Karlskrona, Lund, Örebro, Stockholm, Sundsvall
2025-12
Recruiting
A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)
NCT07012629Covert Brain Infarction
DrugsRosuvastatin·Atorvastatin·Clopidogrel·Aspirin
Aarhus University Hospital
Phase 3
1,652
Lund
2025-11-26
By invitation
Effects of a Web-based Support Programme for Cardiac Arrest Survivors
NCT07240714Cardiac Arrest (CA)
Linkoeping University
Not applicable
120
Gothenburg, Helsingborg, Kalmar, Linköping, Lund, Motala, Norrköping, Västerås
2025-11-20
Recruiting
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
NCT07188805Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
DrugFinerenone
Bayer
Phase 3
111
Lund
2025-11-19
Recruiting
Study the Effect of Plant-based Beverage Consumption on the Gut Microbiome in Healthy Adults
NCT07730229Plant-based Milk, Gastrointestinal Microbiome
Lund University
Not applicable
60
Lund
2025-11-10
Recruiting
Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis
NCT07304271Gastric Cancer Peritoneal Metastases
DrugIntraperitoneal Paclitaxel
Magnus Nilsson
Phase 3
262
Gothenburg, Lund, Örebro, Stockholm, Uppsala
2025-11-05
Recruiting
Study on Orthosis in Cervical Spine Fracture Treatment
NCT06848660Cervical Spine Fractures, Cervical Spine Injury, Rigid Collar
Uppsala University Hospital
Not applicable
616
Gothenburg, Linköping, Lund, Malmö, Umeå, Uppsala
2025-11-01
By invitation
UPSIDES - Recovery Through Peer Support
NCT07407842Mental Illness
Lund University
Not applicable
300
Lund
2025-11-01
Active, closed
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT07076121Pancreatic Ductal Adenocarcinoma
DrugsNavlimetostat·Nab-paclitaxel·Gemcitabine
Bristol-Myers Squibb
Phase 2/3
470
Lund, Stockholm, Uppsala, Gothenburg
2025-10-23
Recruiting
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
NCT07213609Neoplasms, Colorectal, Neoplasms
GlaxoSmithKline
Phase 1/2
47
Lund, Stockholm, Uppsala
2025-10-20
Not yet open
Future Osteoarthritis Treatment - Free Open Online Course for All
NCT07122154Osteoarthritis (OA)
Eva Ekvall-Hansson
Observational
50
Lund
2025-10-15
Recruiting
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285Systemic Lupus Erythematosus (SLE)
Bristol-Myers Squibb
Observational
223
Lund, Solna, Örebro
2025-10-08
Recruiting
Manual Lymph Drainage for External Lymphedema
NCT07215169Lymphedema of Face, Neoplasms, Radiotherapy Side Effect, Lymphedema Due to Radiation
Lund University
Not applicable
40
Lund
2025-10-01
Recruiting
Safety Planning Intervention in Swedish Healthcare: A Multisite Study for Suicide Prevention
NCT07469917Suicide Attempt
Region Skane
Not applicable
8,000
Helsingborg, Kristianstad, Lund, Malmö
2025-10-01
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
NCT07116967Plaque Psoriasis
DrugsUstekinumab·Deucravacitinib
Bristol-Myers Squibb
Phase 3
3,040
Lund, Borås, Uppsala
2025-09-22
Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
NCT07053423Chronic Obstructive Pulmonary Disease
DrugDupilumab
Sanofi
Phase 4
218
Gothenburg, Lund
2025-09-22
Recruiting
Sustained Cord Circulation at Emergency Cesarean Section
NCT06540222Asphyxia Neonatorum, Fetal Hypoxia
Region Skane
Not applicable
2,200
Gothenburg, Halmstad, Linköping, Lund, Malmö, Örebro, Stockholm, Umeå
2025-09-08
Recruiting
Heart-Lung Machine: Impact of the Priming Solution on Acid-Base Balance, Electrolytes and Outcome on Patients Undergoing Cardiac Surgery
NCT07267546Acid Base Imbalance, Osmolality Disturbance, Crystalloid Solutions, Electrolyte Changes
Region Skane
Not applicable
80
Lund
2025-09-01
Not yet open
Effect of Neck Training on Outcomes Related to Sport-Related Concussion
NCT06774976Sport-related Concussion
Lund University
Not applicable
50
Lund
2025-09
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Gothenburg, Lund, Stockholm, Uppsala
2025-08-05
Recruiting
Harmony TPV EMEA PMS
NCT06906926Severe Pulmonary Valve Regurgitation
Medtronic Cardiovascular
Not applicable
80
Lund
2025-07-30
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433Atherosclerotic Cardiovascular Disease, Overweight, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
12,800
Falun, Gothenburg, Helsingborg, Linköping, Lund, Örebro, Stockholm
2025-07-25
Recruiting
SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
NCT06794775Malignant Melanoma Stage III
DrugsIpilimumab·Nivolumab
Hildur Helgadottir
Phase 3
128
Gothenburg, Lund, Stockholm
2025-07-10
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT07052903Transthyretin Amyloidosis With Cardiomyopathy
DrugNucresiran
Alnylam Pharmaceuticals
Phase 3
1,750
Gothenburg, Lund, Solna
2025-07-02
Recruiting
Evaluation Viral RNA and Virus Infectivity in Exhaled Air Before and After Use of One Dose With ColdZyme Mouth Spray
NCT07041671URTI - Viral Upper Respiratory Tract Infection
Lund University
Not applicable
200
Lund
2025-06-30
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Falun, Gothenburg, Helsingborg, Lund, Norrköping, Solna, Stockholm
2025-06-25
Recruiting
Stepped Versus Stratified Care for Anxiety Disorders in Youth
NCT06942429Social Anxiety Disorder, Separation Anxiety Disorder, Specific Phobia, Panic Disorder
Region Skane
Not applicable
556
Lund
2025-06-19
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsSonrotoclax·Venclexta·Obinutuzumab·Venetoclax
BeOne Medicines
Phase 3
630
Gothenburg, Lund, Stockholm, Uppsala
2025-06-11
Recruiting
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
NCT06885034Gastrointestinal Neoplasms
DrugRisvutatug Rezetecan
GlaxoSmithKline
Phase 1/2
451
Gothenburg, Lund, Stockholm, Uppsala
2025-06-11
Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06340568Endometrial Cancer
DrugsDoxorubicin·Docetaxel·Paclitaxel
BioNTech SE
Phase 3
480
Lund, Stockholm, Uppsala
2025-06-10
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Gothenburg, Linköping, Lund, Stockholm, Uppsala
2025-06-10
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
NCT07000357Cardiovascular Disease
DrugAZD0780
AstraZeneca
Phase 3
15,100
Alingsås, Falun, Huddinge, Lidköping, Lund, Östersund, Stockholm, Umeå
2025-06-04
Active, closed
A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
NCT06821542Chronic Graft-versus-host-disease
DrugAxatilimab
Incyte Corporation
Phase 3
9
Gothenburg, Lund, Stockholm, Uppsala
2025-06-04
Recruiting
Long-term Follow-up of Depressive Disorders in Psychiatric Care
NCT07078227Depression, Psychiatric Diagnosis, Personality Disorders, Suicide, Attempted
Region Skane
Observational
415
Lund
2025-06-01
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
NCT06952504Endometrial Cancer
DrugsSacituzumab tirumotecan·Docetaxel·Paclitaxel·Cisplatin
Merck Sharp & Dohme LLC
Phase 3
1,123
Lund, Uppsala
2025-05-22
Active, closed
Proteomic Analysis of Serum Samples After Cardiac Arrest: a TTM-trial Substudy
NCT07017374Cardiac Arrest (CA), Proteomics
Region Skane
Observational
682
Lund
2025-05-22
Recruiting
On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
NCT06877637Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Region Skane
Observational
150
Kristianstad, Lund
2025-05-15
Recruiting
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
NCT06793410Recipients of Allogeneic Stem Cell Transplantation, HPV (Human Papillomavirus)-Associated, Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Vastra Gotaland Region
Phase 2
100
Lund, Stockholm, Uppsala, Linköping, Gothenburg
2025-05-12
Recruiting
Evaluation of Clinical Outcomes of Ponto Procedures Performed in Settings Outside the Main Operating Room (i.e. Out-of-OR)
NCT06930781Hearing Loss, Bone Anchored Hearing Aids
Oticon Medical
Observational
270
Luleå, Lund
2025-05-07
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT06499285Myelodysplastic Syndromes
DrugElritercept
Takeda
Phase 3
225
Örebro, Huddinge, Gothenburg, Lund
2025-05-06
Recruiting
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
NCT06652438Acute Myeloid Leukemia, Adult
DrugRevumenib
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Gothenburg, Lund, Stockholm, Uppsala
2025-05-05
Not yet open
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer
NCT06223698Breast Cancer
DrugsTamoxifen·Exemestane·Anastrozole·Letrozole
Region Örebro County
Phase 3
3,832
Visby, Eskilstuna, Falun, Gävle, Gothenburg, Jönköping, Kalmar, Lund
2025-05-02
Recruiting
Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study
NCT07025694Children With Cerebral Palsy Who Are Ambulant, Cerebral Palsy GMFCS-ER I-II
Lund University
Not applicable
20
Lund
2025-05-01
Recruiting
Skin Type Determination Using Image Artificial Intelligence
NCT07765303Skin Ageing, Skin
Region Skane
Observational
1,500
Lund, Gothenburg
2025-04-28
Recruiting
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
NCT06966401Major Depressive Disorder
DrugNBI-1065845
Neurocrine Biosciences
Phase 3
850
Gothenburg, Lund, Stockholm
2025-04-16
Recruiting
Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction
NCT06515730Left Ventricular Thrombus, Acute Myocardial Infarction
DrugsWarfarin·Apixaban
Karolinska Institutet
Phase 4
212
Falun, Gothenburg, Linköping, Lund, Malmö, Nörrköping, Örebro, Stockholm
2025-04-08
Recruiting
Reperfusion Treatment in Acute Pulmonary Embolism
NCT07003646Pulmonary Embolism
DrugAlteplase
Sahlgrenska University Hospital
Observational
220
Gothenburg, Linköping, Luleå, Lund, Örebro, Stockholm, Uppsala
2025-04-01
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
NCT06989112Endometrial Cancer
DrugsTaxotere·Rilvegostomig·Paraplatin·Taxol
AstraZeneca
Phase 3
600
Linköping, Lund, Stockholm, Uppsala
2025-03-27
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261Chronic Obstructive Pulmonary Disease (COPD)
DrugTezepelumab
AstraZeneca
Phase 3
990
Gothenburg, Karlskrona, Lund, Örebro, Stockholm
2025-03-25
Recruiting
Treatment With Auricular Vagus Nerve Stimulation in Rheumatoid Arthritis - the TRAVAGA Study
NCT06779123Rheumatoid Arthritis (RA)
taVNS AB
Not applicable
128
Lund, Malmö, Örebro, Stockholm, Umeå
2025-03-21
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
NCT06819007Ovarian Cancer
DrugsTrastuzumab deruxtecan·Bevacizumab
Daiichi Sankyo
Phase 3
582
Lund, Solna, Uppsala
2025-03-19
Rows per page Showing 1–100 of 402
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-sweden/city/lund

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,213 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 402 of those studies with a site in Lund.

How many clinical trials are recruiting in Lund?

234 of the 402 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 13 have not yet opened recruitment, 140 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lund), 402 studies
PhaseStudiesRecruitingShare
Phase 31437635.6%
Not applicable1066526.4%
Observational775219.2%
Phase 236199%
Phase 41583.7%
Phase 2/31253%
Phase 1/21182.7%
Phase 1210.5%

Most active sponsors

Lead sponsors with the most studies (Lund)
Lead sponsorStudiesRecruiting
Region Skane6448
Lund University2214
AstraZeneca2113
Karolinska Institutet139
Lund University Hospital1210
Janssen Research & Development, LLC115
Merck Sharp & Dohme LLC104
Vastra Gotaland Region96
Skane University Hospital86
Novartis Pharmaceuticals71
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.